Improving the Standards of Reporting of Clinical Trial Data von Ganju, Jitendra

Volltext

Non-inferiority versus superiority drug claims: the (not so) subtle distinction von Ganju, Jitendra, Rom, Dror

Volltext

Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration von Videnovic, Aleksandar, Pfeiffer, Helle C V, Tylki-Szymańska, Anna, Berry-Kravis, Elizabeth, Ezgü, Fatih, Ganju, Jitendra, Jurecka, Agnieszka, Lang, Anthony E

Volltext

The benefit of stratification in clinical trials revisited von Ganju, Jitendra, Zhou, Kefei

Volltext

Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study von Malfertheiner, Peter, Schultze, Viola, Rosenkranz, Bernd, Kaufmann, Stefan H.E, Ulrichs, Timo, Novicki, Deborah, Norelli, Francesco, Contorni, Mario, Peppoloni, Samuele, Berti, Duccio, Tornese, Daniela, Ganju, Jitendra, Palla, Emanuela, Rappuoli, Rino, Scharschmidt, Bruce F, Del Giudice, Giuseppe

Volltext

Sample size formula for a win ratio endpoint von Yu, Ron Xiaolong, Ganju, Jitendra

Volltext

Sample size formula for a win ratio endpoint von Yu, Ron Xiaolong, Ganju, Jitendra

Volltext

Improving the Standards of Reporting of Clinical Trial Data von Ganju, Jitendra

Volltext

Improving the operational efficiency of Phase 2 and 3 trials von Ganju, Jitendra

Volltext

A new way to address missing data in late-stage clinical trials von Ganju, Jitendra, Yu, Ron Xiaolong

Volltext

Some Unexamined Aspects of Analysis of Covariance in Pretest–Posttest Studies von Ganju, Jitendra

Volltext

Variable Duration Trial as an Alternative Design for Continuous Endpoints von Ganju, Jitendra, Ma, Julie Guoguang

Volltext

Response to ‘Inclusion of Placebos and Blinding for Ascending Dose First‐in‐Human Studies and Other Underpowered Phase 1 studies has not been Justified and on Balance is Not Useful... von Ganju, Jitendra, Dias, Clapton

Volltext

Challenges and strategies for clinical trials in propionic and methylmalonic acidemias von Vockley, Jerry, Burton, Barbara, Jurecka, Agnieszka, Ganju, Jitendra, Leiro, Beth, Zori, Roberto, Longo, Nicola

Volltext

Comments on 'Sample size for equivalence trials: a case study from a vaccine lot consistency trial' von Ganju, Jitendra, Izu, Allen

Volltext

Inference from blinded data in randomized clinical trials von Zhou, Kefei, Ganju, Jitendra

Volltext

Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums von Ganju, Jitendra, Xing, Biao

Volltext

A single test for rejecting the null hypothesis in subgroups and in the overall sample von Lin, Yunzhi, Zhou, Kefei, Ganju, Jitendra

Volltext

Diagnostics for assumptions in moderate to large simple clinical trials: do they really help? by Jonathan J. Shuster, Statistics in Medicine 2005; 24:2431-2438 von Ganju, Jitendra

Volltext

Diagnostics for assumptions in moderate to large simple clinical trials: do they really help? von Ganju, Jitendra

Volltext